• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter: proton pump inhibitor use and fracture risk.

作者信息

Sugiyama T

机构信息

Department of Orthopaedic Surgery, Saitama Medical University, Saitama, Japan.

出版信息

Aliment Pharmacol Ther. 2018 Feb;47(3):449-450. doi: 10.1111/apt.14462.

DOI:10.1111/apt.14462
PMID:29314134
Abstract
摘要

相似文献

1
Letter: proton pump inhibitor use and fracture risk.信函：质子泵抑制剂的使用与骨折风险
Aliment Pharmacol Ther. 2018 Feb;47(3):449-450. doi: 10.1111/apt.14462.
2
Incidence and predictors of osteoporotic fractures in patients with Barrett's oesophagus: a population-based nested case-control study.巴雷特食管患者骨质疏松性骨折的发病率及预测因素：一项基于人群的巢式病例对照研究。
Aliment Pharmacol Ther. 2017 Dec;46(11-12):1094-1102. doi: 10.1111/apt.14345. Epub 2017 Oct 5.
3
Response to letter: 'Proton pump inhibitors therapy and the risk of major osteoporotic nonhip fractures in older adults in Taiwan'.对信件的回复：“台湾老年人质子泵抑制剂治疗与主要骨质疏松性非髋部骨折风险”
Eur J Gastroenterol Hepatol. 2019 Feb;31(2):276. doi: 10.1097/MEG.0000000000001309.
4
Proton pump inhibitor use and the risk of osteoporosis and fracture in stroke patients: a population-based cohort study.质子泵抑制剂的使用与卒中患者骨质疏松症和骨折风险：一项基于人群的队列研究。
Osteoporos Int. 2018 Jan;29(1):153-162. doi: 10.1007/s00198-017-4262-2. Epub 2017 Oct 14.
5
Association of proton pump inhibitors with fracture risk in patients with rheumatoid arthritis.质子泵抑制剂与类风湿关节炎患者骨折风险的关联
Ann Rheum Dis. 2020 Sep;79(9):e110. doi: 10.1136/annrheumdis-2019-215747. Epub 2019 May 31.
6
Letter: proton pump inhibitor usage still seems to reduce the risk of high-grade dysplasia and/or oesophageal adenocarcinoma in Barrett's oesophagus.
Aliment Pharmacol Ther. 2014 Oct;40(7):859-60. doi: 10.1111/apt.12892.
7
Letter: proton pump inhibitor usage still seems to reduce the risk of high-grade dysplasia and/or oesophageal adenocarcinoma in Barrett's oesophagus--authors' reply.信函：质子泵抑制剂的使用似乎仍可降低巴雷特食管中高级别异型增生和/或食管腺癌的风险——作者回复。
Aliment Pharmacol Ther. 2014 Oct;40(7):860-1. doi: 10.1111/apt.12931.
8
Proton Pump Inhibitor Use and Fracture Risk: An Update of Drug Safety Communication Needed?质子泵抑制剂的使用与骨折风险：是否需要更新药品安全信息？
Am J Gastroenterol. 2019 Feb;114(2):360-361. doi: 10.14309/ajg.0000000000000053.
9
Letter: proton pump inhibitors, GERD and oesophageal adenocarcinoma.
Aliment Pharmacol Ther. 2014 Aug;40(3):319. doi: 10.1111/apt.12832.
10
Letter: proton pump inhibitors, GERD and oesophageal adenocarcinoma - authors' reply.
Aliment Pharmacol Ther. 2014 Aug;40(3):320. doi: 10.1111/apt.12847.